Eshallgo (EHGO) Announces 1.25M Share IPO at $4/sh

Eshallgo Inc (Nasdaq: EHGO) today announced the pricing of its initial public offering of 1,250,000 Class A ordinary shares at a public offering price of $4 per Class A ordinary share, for total gross proceeds of $5 million, before deducting underwriting discounts and commissions and offering expenses. The Offering is being conducted on a firm commitment basis. The Class A ordinary shares are expected to commence trading on Nasdaq Capital Market under the ticker symbol "EHGO" on July 2, 2024.

The Company has granted the underwriters of the Offering an option, exercisable within 45 days from the date of the underwriting agreement, to purchase up to an additional 187,500 Class A ordinary shares at the public offering price, less underwriting discounts and commissions. The Offering is expected to close on July 3, 2024, subject to customary closing conditions.

US Tiger Securities, Inc. and Kingswood Capital Partners, LLC are acting as co-underwriters for the Offering. Ortoli Rosenstadt LLP is acting as U.S. counsel to the Company. VCL Law LLP is acting as U.S. counsel to the underwriters with respect to the Offering.

A registration statement on Form F-1, as amended (File No. 333-271478), relating to the Offering was previously filed with the Securities and Exchange Commission ("SEC") by the Company, and subsequently declared effective by the SEC on July 1, 2024. The Offering is being made only by means of a prospectus, forming a part of the registration statement. A final prospectus relating to the Offering will be filed with the SEC and will be available on the SEC's website at www.sec.gov. Electronic copies of the final prospectus related to the Offering may be obtained, when available, from US Tiger Securities, Inc., 437 Madison Avenue, 27th Floor, New York, New York 10022, or by telephone at +1 646-978-5188, or from Kingswood Capital Partners, LLC, 126 E 56^th St, Suite 22S, or by telephone at +1 732- 910- 9692.

Before you invest, you should read the final prospectus and other documents the Company has filed or will file with the SEC for more complete information about the Company and the Offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

You May Also Be Interested In

• Chewy stock falls as meme stock influencer Roaring Kitty reveals 6.6% stake
• Annovis Bio Inc. (ANVS) Announces New Data from Phase III Parkinson’s Study
• Cartesian Therapeutics (RNAC) Enters $130M Private Placement